Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)Dividends Paid - Common (QoQ)Dividends Paid - Common Growth (1y)Dividends Paid - Common Growth (3y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio (QoQ)FCF Payout Ratio Growth (1y)FCF Payout Ratio Growth (3y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)

Others

Iradimed (IRMD) EPS (Basic) Growth (1y) (2014 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) Growth (1y) (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	-18.42%
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	14.04%
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	-11.88%
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	95.65%
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	8.20%
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	92.59%
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	-30.89%
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	51.01%
10	Iradimed	1.17 Bn	1.11 Bn	16.81 Mn	24.32%

Historic Data

Download Data 🔒

Date	Value
Mar 31, 2026	24.32%
Dec 31, 2025	24.39%
Sep 30, 2025	10.00%
Jun 30, 2025	15.38%
Mar 31, 2025	12.12%
Dec 31, 2024	13.89%
Sep 30, 2024	0.00%
Jun 30, 2024	18.18%
Mar 31, 2024	22.22%
Dec 31, 2023	24.14%
Sep 30, 2023	48.15%
Jun 30, 2023	26.92%
Mar 31, 2023	35.00%
Dec 31, 2022	-9.37%
Sep 30, 2022	28.57%
Jun 30, 2022	116.67%
Mar 31, 2022	81.82%
Dec 31, 2021	540.00%
Sep 30, 2021	133.33%
Jun 30, 2021	170.59%
Mar 31, 2021	-26.67%
Dec 31, 2020	-82.14%
Sep 30, 2020	-59.09%
Jun 30, 2020	-189.47%
Mar 31, 2020	-11.76%
Dec 31, 2019	75.00%
Sep 30, 2019	0.00%
Jun 30, 2019	46.15%
Mar 31, 2019	112.50%
Dec 31, 2018	700.00%
Sep 30, 2018	1,000.00%
Jun 30, 2018	333.33%
Mar 31, 2018	500.00%
Dec 31, 2017	-81.82%
Sep 30, 2017	-86.67%
Jun 30, 2017	-85.71%
Mar 31, 2017	-109.52%
Dec 31, 2016	-47.62%
Sep 30, 2016	-11.76%
Jun 30, 2016	31.25%
Mar 31, 2016	50.00%
Dec 31, 2015	2,000.00%
Sep 30, 2015	750.00%
Jun 30, 2015	6.67%
Mar 31, 2015	100.00%
Dec 31, 2014	-85.71%
Sep 30, 2014	-50.00%
Jun 30, 2014	87.50%